Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,761 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00035334 | Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis | completed | Phase 2 / Phase 3 | 150 | Bellus Health Inc. - a GSK companyINDUSTRY | 12 | Feb 14, 2006 | clinicaltrials |
| NCT00111046 | Pain Relief - Tramadol Versus Ibuprofen | unknown | Phase 1 / Phase 2 | 40 | Royal Liverpool University HospitalOTHER_GOV | 1 | Nov 10, 2005 | clinicaltrials |
| NCT00244127 |
| Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL. |
| unknown |
| Phase 2 |
| 75 |
| Zeneus PharmaINDUSTRY |
| 5 |
| Oct 28, 2005 |
| clinicaltrials |
| NCT00134108 | Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients | unknown | N/A | — | NHS Greater Glasgow and ClydeOTHER | 1 | Oct 26, 2005 | clinicaltrials |
| NCT00222664 | Qidong Hepatitis B Intervention Study | completed | Phase 4 | 80,000 | University of OxfordOTHER | 2 | Sep 22, 2005 | clinicaltrials |
| NCT00073385 | Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 225 | Titan PharmaceuticalsINDUSTRY | 3 | Aug 30, 2005 | clinicaltrials |
| NCT00022893 | Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma | unknown | N/A | — | Corixa CorporationINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
| NCT00034333 | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer | terminated | Phase 2 / Phase 3 | 240 | FeRxINDUSTRY | 8 | Jun 24, 2005 | clinicaltrials |
| NCT00052130 | Vaccine Therapy for Patients With Stage III Melanoma | unknown | Phase 3 | 1,118 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00052156 | Vaccine Therapy for Patients With Stage IV Melanoma | unknown | Phase 3 | 670 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00057382 | T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients | terminated | Phase 2 / Phase 3 | 750 | TularikINDUSTRY | 11 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials